| Signature Hospice 834 S Front Street, Central Point, OR, 97502 | |
| (541) 664-7400 |
News Archive
The California Medical Association blocked another bill aimed at improving patient safety yesterday, prompting consumer advocates and families harmed by dangerous doctors to consider amending a pending patient safety ballot measure to include those reforms the legislature fails to enact this year.
Four patients suffering from acute myocarditis after mRNA COVID-19 vaccination suggests that further investigation is needed.
LifePoint Hospitals, Inc. announced today its intention to sell through a private offering $400 million in aggregate principal amount of Senior Notes due 2020. The Notes will be senior unsecured obligations of the Company and will be guaranteed by substantially all of the Company's subsidiaries that guarantee its senior secured credit facilities.
Cancer Council will next week host a free national webinar for women who carry BRCA 1 or BRCA 2 genes for breast cancer.
Researchers are scheduled to present Phase I data relating to Semafore Pharmaceuticals' lead product candidate, SF1126, as a treatment for patients with relapsed and refractory myeloma during the 51st American Society of Hematology (ASH) Annual Meeting, December 5 - 8, 2009, at the Ernst N. Morial Convention Center in New Orleans, LA.
› Verified 7 days ago
| Name | Signature Hospice |
|---|---|
| Location | 834 S Front Street, Central Point, Oregon |
| Hospice ID | 381560 |
| Category | Freestanding Hospice |
| Ownership Type | Proprietary - Partnership |
| Profit Type | FOR PROFIT |
| SSA county code | 140 |
News Archive
The California Medical Association blocked another bill aimed at improving patient safety yesterday, prompting consumer advocates and families harmed by dangerous doctors to consider amending a pending patient safety ballot measure to include those reforms the legislature fails to enact this year.
Four patients suffering from acute myocarditis after mRNA COVID-19 vaccination suggests that further investigation is needed.
LifePoint Hospitals, Inc. announced today its intention to sell through a private offering $400 million in aggregate principal amount of Senior Notes due 2020. The Notes will be senior unsecured obligations of the Company and will be guaranteed by substantially all of the Company's subsidiaries that guarantee its senior secured credit facilities.
Cancer Council will next week host a free national webinar for women who carry BRCA 1 or BRCA 2 genes for breast cancer.
Researchers are scheduled to present Phase I data relating to Semafore Pharmaceuticals' lead product candidate, SF1126, as a treatment for patients with relapsed and refractory myeloma during the 51st American Society of Hematology (ASH) Annual Meeting, December 5 - 8, 2009, at the Ernst N. Morial Convention Center in New Orleans, LA.
› Verified 7 days ago
| NPI Number | 1548503477 |
| Organization Name | Northwest Hospice, Llc |
| Address | 834 S Front St Central Point, Oregon, 97502 |
| Phone Number | (541)664-7400 |
News Archive
The California Medical Association blocked another bill aimed at improving patient safety yesterday, prompting consumer advocates and families harmed by dangerous doctors to consider amending a pending patient safety ballot measure to include those reforms the legislature fails to enact this year.
Four patients suffering from acute myocarditis after mRNA COVID-19 vaccination suggests that further investigation is needed.
LifePoint Hospitals, Inc. announced today its intention to sell through a private offering $400 million in aggregate principal amount of Senior Notes due 2020. The Notes will be senior unsecured obligations of the Company and will be guaranteed by substantially all of the Company's subsidiaries that guarantee its senior secured credit facilities.
Cancer Council will next week host a free national webinar for women who carry BRCA 1 or BRCA 2 genes for breast cancer.
Researchers are scheduled to present Phase I data relating to Semafore Pharmaceuticals' lead product candidate, SF1126, as a treatment for patients with relapsed and refractory myeloma during the 51st American Society of Hematology (ASH) Annual Meeting, December 5 - 8, 2009, at the Ernst N. Morial Convention Center in New Orleans, LA.
› Verified 7 days ago
| Quality Measure | Provider Score | National Score |
|---|---|---|
| Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | 100.0 | 98.3 |
| Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | 100.0 | 93.6 |
| Patients who were checked for pain at the beginning of hospice care | 98.4 | 93.9 |
| Patients who got a timely and thorough pain assessment when pain was identified as a problem | 84.8 | 77.7 |
| Patients who were checked for shortness of breath at the beginning of hospice care | 100.0 | 97.3 |
| Patients who got timely treatment for shortness of breath | 100.0 | 94.6 |
| Patients taking opioid pain medication who were offered care for constipation | 100.0 | 93.3 |
News Archive
The California Medical Association blocked another bill aimed at improving patient safety yesterday, prompting consumer advocates and families harmed by dangerous doctors to consider amending a pending patient safety ballot measure to include those reforms the legislature fails to enact this year.
Four patients suffering from acute myocarditis after mRNA COVID-19 vaccination suggests that further investigation is needed.
LifePoint Hospitals, Inc. announced today its intention to sell through a private offering $400 million in aggregate principal amount of Senior Notes due 2020. The Notes will be senior unsecured obligations of the Company and will be guaranteed by substantially all of the Company's subsidiaries that guarantee its senior secured credit facilities.
Cancer Council will next week host a free national webinar for women who carry BRCA 1 or BRCA 2 genes for breast cancer.
Researchers are scheduled to present Phase I data relating to Semafore Pharmaceuticals' lead product candidate, SF1126, as a treatment for patients with relapsed and refractory myeloma during the 51st American Society of Hematology (ASH) Annual Meeting, December 5 - 8, 2009, at the Ernst N. Morial Convention Center in New Orleans, LA.
› Verified 7 days ago
| Home Health Aides | 2 |
| Counselors | 2 |
| Licensed Practical or Vocational Nurses | 2 |
| Medical Social Workers | 1 |
| Physicians | 1 |
| Registered Nurses | 4 |
| Other Personnel | 3 |
| Total Employees | 15 |
|---|
News Archive
The California Medical Association blocked another bill aimed at improving patient safety yesterday, prompting consumer advocates and families harmed by dangerous doctors to consider amending a pending patient safety ballot measure to include those reforms the legislature fails to enact this year.
Four patients suffering from acute myocarditis after mRNA COVID-19 vaccination suggests that further investigation is needed.
LifePoint Hospitals, Inc. announced today its intention to sell through a private offering $400 million in aggregate principal amount of Senior Notes due 2020. The Notes will be senior unsecured obligations of the Company and will be guaranteed by substantially all of the Company's subsidiaries that guarantee its senior secured credit facilities.
Cancer Council will next week host a free national webinar for women who carry BRCA 1 or BRCA 2 genes for breast cancer.
Researchers are scheduled to present Phase I data relating to Semafore Pharmaceuticals' lead product candidate, SF1126, as a treatment for patients with relapsed and refractory myeloma during the 51st American Society of Hematology (ASH) Annual Meeting, December 5 - 8, 2009, at the Ernst N. Morial Convention Center in New Orleans, LA.
› Verified 7 days ago
| Signature Hospice Location: 834 S Front Street, Central Point, Oregon, 97502 Phone: (541) 664-7400 |